“…[12][13][14] Currently, 3D bioprinting improved the application of tissue structure in drug screening, [15,16] disease modeling, [17,18] and tissue repair and regenerative medicine. [19,20] Most of importantly, heart, [21,22] blood vessels, [23,24] bone, [25,26] cartilage, [27,28] liver, [1,29,30] lung, [1,31] eye, [32,33] neuronal tissue, [34,35] and pancreatic tissue [36] have been successfully designed and developed through 3D extrusion-based bioprinting and DLPbased bioprinting strategies (Figure 1A). However, the resolution of extrusion-based 3D bioprinting structure is relatively limited, and the resolution of conventional extrusion printing is usually less than 200 μm, and the obtained structure is also easy to cause stress relaxation and permanent deformation due to the different crosslinking rate during the printing process.…”